Valuation : Orthofix International NV

Market Cap 363M 312M 294M 268M 502M 34.7B 506M 3.51B 1.35B 17.6B 1.36B 1.33B 55.9B P/E 2026 *
-7.58x
P/E 2027 * -9.43x
Enterprise Value 363M 312M 294M 268M 502M 34.7B 506M 3.51B 1.35B 17.6B 1.36B 1.33B 55.9B EV / Sales 2026 *
0.43x
EV / Sales 2027 * 0.42x
Free-Float
97.83%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 66 16/03/2016
Director/Board Member 54 08/06/2020
Director/Board Member 64 05/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 363M
-1.09%-4.38%-19.58%+1.54% 182B
-0.44%-1.73%-0.90%+12.39% 118B
+0.10%-4.01%+9.24%+82.14% 61.7B
-0.32%-5.26%+12.44%+44.05% 50.55B
-1.78%-5.57%-5.98%-33.69% 48.98B
+0.73%-5.63%+11.39%-21.09% 31.65B
-2.57%-9.70% - - 29.87B
-1.13%-2.70%+30.66%-16.04% 23.71B
-1.46%-9.48%-14.50%+4.76% 21.78B
Average -0.67%-4.02%+2.85%+9.26% 63.1B
Weighted average by Cap. -0.82%-3.00%-3.71%+11.97%

Financials

2026 *2027 *
Net sales 851M 732M 690M 629M 1.18B 81.36B 1.19B 8.22B 3.16B 41.27B 3.2B 3.13B 131B 872M 750M 708M 645M 1.2B 83.36B 1.22B 8.43B 3.24B 42.28B 3.27B 3.2B 134B
Net income -42.26M -36.34M -34.29M -31.24M -58.4M -4.04B -58.93M -408M -157M -2.05B -159M -155M -6.51B -43.06M -37.03M -34.94M -31.83M -59.5M -4.12B -60.04M -416M -160M -2.09B -162M -158M -6.63B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!